Effects of dopexamine on blood flow and inflammation in sepsis model in rats
Author Information
Author(s): Jürgen Birnbaum, Edda Klotz, Claudia D Spies, Björn Lorenz, Patrick Stuebs, Ortrud Hein, Matthias Gründling, Dragan Pavlovic, Taras Usichenko, Michael Wendt, Wolfgang J Kox, Christian Lehmann
Primary Institution: Charité-University Medicine Berlin
Hypothesis
Can dopexamine improve hepatosplanchnic perfusion in experimental sepsis?
Conclusion
Dopexamine administration improved intestinal microvascular blood flow and reduced leucocyte activation in experimental sepsis.
Supporting Evidence
- IMBF decreased significantly in the LPS group compared to baseline.
- Dopexamine improved IMBF values to levels similar to controls.
- FCD was improved in both muscle layers with dopexamine treatment.
- Leucocyte adherence was reduced by dopexamine in the DPX group.
- TNF-α levels were significantly lower in the DPX group compared to LPS group.
Takeaway
Dopexamine helps blood flow in the intestines and reduces inflammation in sick rats.
Methodology
This was a randomized controlled study using 42 Wistar rats divided into three groups, with one group receiving dopexamine after endotoxin infusion.
Limitations
The study did not measure cardiac output and global splanchnic blood flow, which could provide more data for interpretation.
Participant Demographics
42 male Wistar rats, aged 6-8 weeks, weighing 200-250 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website